Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Arezo Azizi, Filippa N. Norsker, Marietta Kokla, Thomas T. Nielsen, Anna S. Holmqvist, Ingrid Øra, Kim Vettenranta, Hilde Øfstaas, Henrik Hasle, Catherine Rechnitzer, Jeanette F. Winther & Line Kenborg. (2023) Pregnancy outcomes in female survivors of neuroblastoma: a short report from the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) study. Acta Oncologica 62:12, pages 1635-1641.
Read now
Read now
KO McNerney, S Karageorgos, GM Ferry, AJ Wolpaw, C Burudpakdee, P Khurana, CN Toland, R Vemu, A Vu, MD Hogarty & H Bassiri. (2022) TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy. OncoImmunology 11:1.
Read now
Read now
Rachel Huey, Dan Rathbone, Paul McCarron & Susan Hawthorne. (2019) Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells. Journal of Drug Targeting 27:9, pages 959-970.
Read now
Read now
Articles from other publishers (57)
Kevin Campbell, David A. Siegel, Puja J. Umaretiya, Shifan Dai, Andras Heczey, Philip J. Lupo, Jeremy M. Schraw, Trevor D. Thompson, Michael E. Scheurer & Jennifer H. Foster. (2023) A comprehensive analysis of neuroblastoma incidence, survival, and racial and ethnic disparities from 2001 to 2019. Pediatric Blood & Cancer 71:1.
Crossref
Crossref
Lei Lin, Bo Wang, Xinxin Zhang, Changmi Deng, Chunlei Zhou, Jinhong Zhu, Haiyan Wu & Jing He. (2023)
Functional
TET2
gene polymorphisms increase the risk of neuroblastoma in Chinese children
. IUBMB Life.
Crossref
Crossref
Jiaming Chang, Lei Lin, Chunlei Zhou, Xinxin Zhang, Tianyou Yang, Haiyan Wu, Yan Zou & Jing He. (2023)
Functional polymorphisms of the
TET1
gene increase the risk of neuroblastoma in Chinese children
. Journal of Cellular and Molecular Medicine 27:15, pages 2239-2248.
Crossref
Crossref
Tahereh Hojjatipour, Zahra Sharifzadeh, Amirhosein Maali & Mehdi Azad. (2023) Chimeric antigen receptor-natural killer cells: a promising sword against insidious tumor cells. Human Cell 36:6, pages 1843-1864.
Crossref
Crossref
Xiaoyu Zhuo, Liangfeng Xia, Wenjing Tang & Wenqi He. (2023) A practical nomogram and risk stratification system for predicting survival outcomes in neuroblastoma patients: a SEER population-based study. Journal of Cancer Research and Clinical Oncology.
Crossref
Crossref
Mingzhen Li, Xiaoying Duan, Di You & Linlin Liu. (2023) Construction of a novel clinical nomogram to predict cancer-specific survival in patients with primary malignant adrenal tumors: a large population-based retrospective study. Frontiers in Medicine 10.
Crossref
Crossref
Maria A. Karalexi, Marina Servitzoglou, Vassilios Papadakis, Denis Kachanov, Maja Česen Mazič, Margaret Baka, Maria Moschovi, Maria Kourti, Sofia Polychronopoulou, Eftichia Stiakaki, Emmanuel Hatzipantelis, Helen Dana, Kalliopi Stefanaki, Astero Malama, Marios S. Themistocleous, Katerina Strantzia, Tatyana Shamanskaya, Panagiota Bouka, Paraskevi Panagopoulou, Maria Kantzanou, Evangelia Ntzani, Nick Dessypris & Eleni Th. Petridou. (2023) Survival patterns of childhood neuroblastoma: an analysis of clinical data from Southern-Eastern European countries. European Journal of Cancer Prevention 32:3, pages 254-263.
Crossref
Crossref
Weiming Chen, Ping Lin, Jianxi Bai, Yifan Fang & Bing Zhang. (2023) Establishment and validation of a nomogram to predict cancer-specific survival in pediatric neuroblastoma patients. Frontiers in Pediatrics 11.
Crossref
Crossref
Kelly Lankin, Cynthia M. LaFond & Alyssa Yost. (2023)
Nurses’ Experiences Caring for Children With Neuroblastoma Receiving
131
I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study
. Journal of Pediatric Hematology/Oncology Nursing 40:2, pages 82-90.
Crossref
Crossref
Lei Lin, Changmi Deng, Chunlei Zhou, Xinxin Zhang, Jinhong Zhu, Jiabin Liu, Haiyan Wu & Jing He. (2023) NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk. Gene 854, pages 147120.
Crossref
Crossref
Nobuhiro Akita, Ryu Okada, Kyosuke Mukae, Ryuichi P. Sugino, Hisanori Takenobu, Koji Chikaraishi, Hidemasa Ochiai, Yohko Yamaguchi, Miki Ohira, Haruhiko Koseki & Takehiko Kamijo. (2023) Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death. Experimental Cell Research 422:1, pages 113412.
Crossref
Crossref
Aleksandra Wieczorek, Joanna Stefanowicz, Marcin Hennig, Elzbieta Adamkiewicz-Drozynska, Marzena Stypinska, Bozenna Dembowska-Baginska, Zuzanna Gamrot, Mariola Woszczyk, Julia Geisler, Tomasz Szczepanski, Szymon Skoczen, Marek Ussowicz, Monika Pogorzala, Szymon Janczar & Walentyna Balwierz. (2022) Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group. BMC Cancer 22:1.
Crossref
Crossref
Bernard Sebastien, Peter Cheverton, Catherine Magnin, Jihane Aouni & Remi Castan. (2022) Development and validation of a predictive model to guide the use of plerixafor in pediatric population. Bone Marrow Transplantation 57:12, pages 1827-1832.
Crossref
Crossref
Balanescu Laura, Balanescu Radu, Cimpeanu Patricia & Moga Andreea. (2022) Association of Image-Defined Risk Factors with Clinical, Biological Features and Outcome in Neuroblastoma. Children 9:11, pages 1707.
Crossref
Crossref
Anup S. Pathania, Philip Prathipati, Swati P. Murakonda, Ajay B. Murakonda, Ankit Srivastava, Avadhesh, Siddappa N. Byrareddy, Don W. Coulter, Subash C. Gupta & Kishore B. Challagundla. (2022) Immune checkpoint molecules in neuroblastoma: A clinical perspective. Seminars in Cancer Biology 86, pages 247-258.
Crossref
Crossref
Zhenjian Zhuo, Lei Lin, Lei Miao, Meng Li & Jing He. (2022) Advances in liquid biopsy in neuroblastoma. Fundamental Research 2:6, pages 903-917.
Crossref
Crossref
Ilia N. Buhtoiarov, Sudipto Mukherjee & Tomas Radivoyevitch. (2022) Incidence, Clinical Features, and Outcomes of Langerhans Cell Histiocytosis in the United States. Journal of Pediatric Hematology/Oncology 44:7, pages e1006-e1015.
Crossref
Crossref
Cynthia M. LaFond, Alyssa Yost, Kelly Lankin, Megha Kilaru & Susan L. Cohn. (2022)
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for
131
I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study
. Journal of Pediatric Hematology/Oncology Nursing 39:5, pages 304-316.
Crossref
Crossref
Emily R. Webb, Julia Moreno-Vicente, Alistair Easton, Silvia Lanati, Martin Taylor, Sonya James, Emily L. Williams, Vikki English, Chris Penfold, Stephen A. Beers & Juliet C. Gray. (2022) Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma. iScience 25:9, pages 104995.
Crossref
Crossref
Ayda Baghery Saghchy Khorasani, Amir-Mohammad Yousefi & Davood Bashash. (2022) CAR NK cell therapy in hematologic malignancies and solid tumors; obstacles and strategies to overcome the challenges. International Immunopharmacology 110, pages 109041.
Crossref
Crossref
Lei Lin, Lei Miao, Huiran Lin, Jiwen Cheng, Meng Li, Zhenjian Zhuo & Jing He. (2022) Targeting RAS in neuroblastoma: Is it possible?. Pharmacology & Therapeutics 236, pages 108054.
Crossref
Crossref
Anup S. Pathania, Philip Prathipati, Omalla A. Olwenyi, Srinivas Chava, Oghenetejiri V. Smith, Subash C. Gupta, Nagendra K. Chaturvedi, Siddappa N. Byrareddy, Don W. Coulter & Kishore B. Challagundla. (2022) miR-15a and miR-15b modulate natural killer and CD8+T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma. Molecular Therapy - Oncolytics 25, pages 308-329.
Crossref
Crossref
Xin Yin, Huiran Lin, Lei Lin, Lei Miao, Jing He & Zhenjian Zhuo. (2022) LncRNAs and CircRNAs in cancer. MedComm 3:2.
Crossref
Crossref
Taylor J Aiken, Amy K Erbe, Lauren Zebertavage, David Komjathy, Arika S Feils, Matthew Rodriguez, Ashley Stuckwisch, Stephen D Gillies, Zachary S Morris, Jen Birstler, Alexander L Rakhmilevich & Paul M Sondel. (2022) Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma. Journal for ImmunoTherapy of Cancer 10:5, pages e004834.
Crossref
Crossref
Etan Orgel, Doojduen Villaluna, Mark D Krailo, Adam Esbenshade, Lillian Sung & David R Freyer. (2022) Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431. The Lancet Oncology 23:5, pages 570-572.
Crossref
Crossref
Barbara SpitzerKayleigh D. RutherfordGunes GundemErin M. McGovern, Nathan E. MillardJuan E. Arango OssaIrene Y. Cheung, Teng Gao, Max F. LevineYanming ZhangJuan S. Medina-Martínez, Yi FengRyan N. Ptashkin, Kelly L. BoltonNoushin FarnoudYangyu ZhouMinal A. PatelGeorgios Asimomitis, Cassidy C. CobbsNeeman MohibullahKety H. Huberman, Maria E. ArcillaBrian H. KushnerShakeel ModakAndrew L. KungAhmet Zehir, Ross L. LevineScott A. ArmstrongNai Kong V. Cheung & Elli Papaemmanuil. (2022) Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies Clones that Predict Therapy-Related Leukemia. Clinical Cancer Research 28:8, pages 1614-1627.
Crossref
Crossref
Pedro Ozorio Brum, Guilherme Danielski Viola, Carolina Saibro-Girardi, Camila Tiefensee-Ribeiro, Matheus Ozorio Brum, Juciano Gasparotto, Rachel Krolow, José Cláudio Fonseca Moreira & Daniel Pens Gelain. (2021) Hypoxia-Inducible Factor-1α (HIF-1α) Inhibition Impairs Retinoic Acid-Induced Differentiation in SH-SY5Y Neuroblastoma Cells, Leading to Reduced Neurite Length and Diminished Gene Expression Related to Cell Differentiation. Neurochemical Research 47:2, pages 409-421.
Crossref
Crossref
Qinghua Chen, Gang Chen & Shuofang Zhao. (2022) MiR-218 Promotes Adriamycin-Induced H9C2 Apoptosis by Inhibiting Stress-Associated Endoplasmic Reticulum Protein 1. Disease Markers 2022, pages 1-10.
Crossref
Crossref
Zhong Jiang, Xianjun Zhou, Lulu Han, Fujiang Li, Xiwei Hao, Qian Dong & Xin Chen. (2022) miR-21 Targets Long Noncoding RNA PCAT29 to Promote Cell Proliferation in Neuroblastoma. Critical Reviews in Eukaryotic Gene Expression 32:8, pages 1-8.
Crossref
Crossref
E. A. Mikhailova, S. A. Kulyova, S. V. Ivanova, S. N. Novikov, E. M. Senchurov, E. D. Gumbatova, R. I. Khabarova, K. M. Borokshinova & A. A. Gogun. (2021) Experience with stereotaxis in patient with local relapse of neuroblastoma in central nervous system in context of combination therapy. Medical alphabet 1:31, pages 25-30.
Crossref
Crossref
Roberto Ciaccio, Piergiuseppe De Rosa, Sara Aloisi, Marta Viggiano, Leonardo Cimadom, Suleman Khan Zadran, Giovanni Perini & Giorgio Milazzo. (2021) Targeting Oncogenic Transcriptional Networks in Neuroblastoma: From N-Myc to Epigenetic Drugs. International Journal of Molecular Sciences 22:23, pages 12883.
Crossref
Crossref
Yuta Kanamori, Alessia Finotti, Laura Di Magno, Gianluca Canettieri, Tomoaki Tahara, Fabio Timeus, Antonio Greco, Paola Tirassa, Jessica Gasparello, Pasquale Fino, Carlo Di Liegro, Patrizia Proia, Gabriella Schiera, Italia Di Liegro, Roberto Gambari & Enzo Agostinelli. (2021) Enzymatic Spermine Metabolites Induce Apoptosis Associated with Increase of p53, caspase-3 and miR-34a in Both Neuroblastoma Cells, SJNKP and the N-Myc-Amplified Form IMR5. Cells 10:8, pages 1950.
Crossref
Crossref
Yaya Chu, Gaurav Nayyar, Susiyan Jiang, Jeremy M. Rosenblum, Patrick Soon-Shiong, Jeffrey T Safrit, Dean A. Lee & Mitchell S. Cairo. (2021)
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2
+
pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice
. Journal for ImmunoTherapy of Cancer 9:7, pages e002267.
Crossref
Crossref
Faroogh Marofi, Alaa S. Al-Awad, Heshu Sulaiman Rahman, Alexander Markov, Walid Kamal Abdelbasset, Yulianna Ivanovna Enina, Mahnaz Mahmoodi, Ali Hassanzadeh, Mahboubeh Yazdanifar, Max Stanley Chartrand & Mostafa Jarahian. (2021) CAR-NK Cell: A New Paradigm in Tumor Immunotherapy. Frontiers in Oncology 11.
Crossref
Crossref
Bin He, Jianshui Mao & Leyi Huang. (2021) Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis. Frontiers in Oncology 11.
Crossref
Crossref
Zengchun Hu, Chuandong Cheng, Yue Wang, Tianrui Chen, Junhong Tu, Chaoshi Niu, Rong Xing, Yang Wang & Yinghui Xu. (2021) Synergistic Effect of Statins and Abiraterone Acetate on the Growth Inhibition of Neuroblastoma via Targeting Androgen Receptor. Frontiers in Oncology 11.
Crossref
Crossref
Kristine Karkoska, Kiersten Ricci, Katherine VandenHeuvel, Andrew T. Trout, Ethan A. Smith, Meera Kotagal & Brian Weiss. (2021) Metastatic neuroblastoma masquerading as infantile hemangioma in a 4‐month‐old child. Pediatric Blood & Cancer 68:5.
Crossref
Crossref
Atif Zafar, Wei Wang, Gang Liu, Xinjie Wang, Wa Xian, Frank McKeon, Jennifer Foster, Jia Zhou & Ruiwen Zhang. (2020) Molecular targeting therapies for neuroblastoma: Progress and challenges. Medicinal Research Reviews 41:2, pages 961-1021.
Crossref
Crossref
FengLing ShaoZhenni WangShan Wang. (2021)
Identification of
MYCN
-Related Gene as a Potential Biomarker for Neuroblastoma Prognostic Model by Integrated Analysis and Quantitative Real-Time PCR
. DNA and Cell Biology 40:2, pages 332-347.
Crossref
Crossref
Wafaa N. Aldhafiri, Yashpal S. Chhonker, Yuning Zhang, Don W. Coulter, Timothy R. McGuire, Rongshi Li & Daryl J. Murry. (2020) Assessment of Tissue Distribution and Metabolism of MP1, a Novel Pyrrolomycin, in Mice Using a Validated LC-MS/MS Method. Molecules 25:24, pages 5898.
Crossref
Crossref
Yan Su, Lijun Wang, Qian Zhao, Zhixia Yue, Wen Zhao, Xisi Wang, Chao Duan, Mei Jin, Dawei Zhang, Shenglan Chen, Jianfeng Yin, Lihua Qiu, Xianfeng Cheng, Zhong Xu & Xiaoli Ma. (2020)
Implementation of the plasma
MYCN
/
NAGK
ratio to detect
MYCN
amplification in patients with neuroblastoma
. Molecular Oncology 14:11, pages 2884-2893.
Crossref
Crossref
Emily R. Webb, Silvia Lanati, Carol Wareham, Alistair Easton, Stuart N. Dunn, Tatyana Inzhelevskaya, Freja M. Sadler, Sonya James, Margaret Ashton-Key, Mark S. Cragg, Stephen A. Beers & Juliet C. Gray. (2020) Immune characterization of pre-clinical murine models of neuroblastoma. Scientific Reports 10:1.
Crossref
Crossref
Venugopal Gunda, Anup S. Pathania, Srinivas Chava, Philip Prathipati, Nagendra K. Chaturvedi, Don W. Coulter, Manoj K. Pandey, Donald L. Durden & Kishore B. Challagundla. (2020) Amino Acids Regulate Cisplatin Insensitivity in Neuroblastoma. Cancers 12:9, pages 2576.
Crossref
Crossref
Kevin X. Liu & Shweta Joshi. (2020) “Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma. Frontiers in Immunology 11.
Crossref
Crossref
Giuseppe Giglia, Giuditta Gambino & Pierangelo Sardo. (2020) Through Predictive Personalized Medicine. Brain Sciences 10:9, pages 594.
Crossref
Crossref
Kevin O. McNerney, Spyridon A. Karageorgos, Michael D. Hogarty & Hamid Bassiri. (2020) Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells. Frontiers in Immunology 11.
Crossref
Crossref
A. Cañete. (2020) High-risk neuroblastoma: where do we go?. Annals of Oncology 31:3, pages 326-327.
Crossref
Crossref
Shengxiang Chen, Wenfeng Tang, Randong Yang, Xiaoxiao Hu & Zhongrong Li. (2020) Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004–2013. The American Surgeon 86:2, pages 127-133.
Crossref
Crossref
Silvia Grasso, Davide Cangelosi, Jennifer Chapelle, Melissa Alzona, Giorgia Centonze, Alessia Lamolinara, Vincenzo Salemme, Costanza Angelini, Alessandro Morellato, Andrea Saglietto, Federico Tommaso Bianchi, Sara Cabodi, Iris Chiara Salaroglio, Federica Fusella, Marzia Ognibene, Manuela Iezzi, Annalisa Pezzolo, Valeria Poli, Ferdinando Di Cunto, Alessandra Eva, Chiara Riganti, Luigi Varesio, Emilia Turco & Paola Defilippi. (2019) The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma. Cell Death & Differentiation 27:2, pages 790-807.
Crossref
Crossref
Jacqueline Clavel, Brigitte Lacour & Paula Rios. 2020. Neuroblastoma. Neuroblastoma
3
15
.
Srinivas Chava, C. Patrick Reynolds, Anup S. Pathania, Santhi Gorantla, Larisa Y. Poluektova, Don W. Coulter, Subash C. Gupta, Manoj K. Pandey & Kishore B. Challagundla. (2019) miR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Molecular Oncology 14:1, pages 180-196.
Crossref
Crossref
Julie Voeller, Amy K. Erbe, Jacob Slowinski, Kayla Rasmussen, Peter M. Carlson, Anna Hoefges, Sabrina VandenHeuvel, Ashley Stuckwisch, Xing Wang, Stephen D. Gillies, Ravi B. Patel, Alvin Farrel, Jo Lynne Rokita, John Maris, Jacquelyn A. Hank, Zachary S. Morris, Alexander L. Rakhmilevich & Paul M. Sondel. (2019) Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Tomoko Iehara, Akihiro Yoneda, Isao Yokota, Hideto Takahashi, Satoshi Teramukai, Takehiko Kamijyo, Atsuko Nakazawa, Tetsuya Takimoto, Atsushi Kikuta, Shigeki Yagyu, Hitoshi Ikeda, Akira Nakagawara & Tatsuro Tajiri. (2019) Results of a prospective clinical trial JN‐L‐10 using image‐defined risk factors to inform surgical decisions for children with low‐risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee. Pediatric Blood & Cancer 66:11.
Crossref
Crossref
Xiaozhi Li & Yutong Meng. (2019) A prognostic nomogram for neuroblastoma in children. PeerJ 7, pages e7316.
Crossref
Crossref
Wei Yao, Kai Li, Kui-Ran Dong, Shan Zheng & Xian-Min Xiao. (2018) Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China. World Journal of Pediatrics 15:2, pages 148-152.
Crossref
Crossref
Christoph Castellani, Georg Singer, Margarita Eibisberger, Beate Obermüller, Gert Warncke, Wolfram Miekisch, Dagmar Kolb-Lenz, Gregor Summer, Theresa M. Pauer, Ahmed ElHaddad, Karl Kashofer & Holger Till. (2019) The effects of neuroblastoma and chemotherapy on metabolism, fecal microbiome, volatile organic compounds, and gut barrier function in a murine model. Pediatric Research 85:4, pages 546-555.
Crossref
Crossref
D. A. Zvyagintseva, S. A. Kuleva & S. V. Ivanova. (2019) The first experience of using immunotherapy in a patient with a recurrence of neuroblastoma. Russian Journal of Children Hematology and Oncology 5:4, pages 94-97.
Crossref
Crossref